Shanghai Pharmaceuticals Holding Co., Ltd. (SH PHARMA, 02607) has scheduled a board meeting for Monday, 30 March 2026. The agenda includes:
• Approval of the consolidated financial results for the year ended 31 December 2025.
• Consideration of the publication of the annual results announcement.
• Discussion on the declaration and amount of a potential final dividend.
The meeting will be chaired by Mr. Yang Qiuhua, who heads a 10-member board comprising four executive directors, one non-executive director, one employee director and four independent non-executive directors.
The notice was released in Shanghai on 18 March 2026.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.
Comments